BACKGROUND: The development of hand osteoarthritis (HOA) and its progression into the erosive subset are unclear, but inflammation is suspected to be the main source. To verify the involvement of inflammation in HOA pathogenesis, we evaluate serum inflammatory mediators and their association with HOA-related clinical features in patients. METHODS: 153 participants (50 non-erosive HOA patients, 54 erosive HOA patients, and 49 healthy control subjects) were included in this study. All patients underwent clinical examination, which included assessment of tender and swollen small hand joints, ultrasound (US) examination, and self-reported measures (e.g., AUSCAN or algofunctional indexes). Serum inflammatory mediators were quantified using human cytokine 27-plex immunoassay. We employed linear modelling, correlation analysis, and resampling statistics to evaluate the association of these mediators to HOA. RESULTS: We identified increased levels of nine inflammatory mediators (e.g., eotaxin, monocyte chemoattractant protein 1, interleukin-8, and tumour necrosis factor) in HOA patients compared to healthy controls. Increased mediators correlated with ultrasound findings as well as with clinically tender and swollen joint counts in patients with erosive HOA. However, none of the mediators distinguished between erosive and non-erosive HOA subtypes. CONCLUSION: Our findings support the hypothesis on the involvement of inflammation in HOA.

Department of Rheumatology 1st Faculty of Medicine Charles University 128 00 Prague Czech Republic

Institute of Rheumatology 128 00 Prague Czech Republic

Zobrazit více v PubMed

Kloppenburg M., Berenbaum F. Osteoarthritis year in review 2019: Epidemiology and therapy. Osteoarthr. Cartil. 2020;28:242–248. doi: 10.1016/j.joca.2020.01.002. PubMed DOI

James S.L., Abate D., Abate K.H., Abay S.M., Abbafati C., Abbasi N., Abbastabar H., Abd-Allah F., Abdela J., Abdelalim A., et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–1858. doi: 10.1016/S0140-6736(18)32279-7. PubMed DOI PMC

Kalichman L., Hernández-Molina G. Hand osteoarthritis: An epidemiological perspective. Semin. Arthritis Rheum. 2010;39:465–476. doi: 10.1016/j.semarthrit.2009.03.001. PubMed DOI

Mathiessen A., Conaghan P.G. Synovitis in osteoarthritis: Current understanding with therapeutic implications. Arthritis Res. 2017;19:1–9. doi: 10.1186/s13075-017-1229-9. PubMed DOI PMC

Gazeley D.J., Yeturi S., Patel P.J., Rosenthal A.K. Erosive osteoarthritis: A systematic analysis of definitions used in the literature. Semin. Arthritis Rheum. 2016;46:395–403. doi: 10.1016/j.semarthrit.2016.08.013. PubMed DOI PMC

Hurnakova J., Hulejová H., Zavada J., Hánová P., Komarc M., Mann H., Klein M., Šléglová O., Olejárová M., Forejtova S., et al. Relationship between serum calprotectin (S100A8/9) and clinical, laboratory and ultrasound parameters of disease activity in rheumatoid arthritis: A large cohort study. PLoS ONE. 2017;12:e0183420. doi: 10.1371/journal.pone.0183420. PubMed DOI PMC

Haugen I.K., Slatkowsky-Christensen B., Bøyesen P., Sesseng S., Van Der Heijde D., Kvien T.K. MRI findings predict radiographic progression and development of erosions in hand osteoarthritis. Ann. Rheum. Dis. 2016;75:117–123. doi: 10.1136/annrheumdis-2014-205949. PubMed DOI

Haugen I.K., Mathiessen A., Slatkowskychristensen B., Magnusson K., Bøyesen P., Sesseng S., Van Der Heijde D., Kvien T.K., Hammer H.B. Synovitis and radiographic progression in non-erosive and erosive hand osteoarthritis: Is erosive hand osteoarthritis a separate inflammatory phenotype? Osteoarthr. Cartil. 2016;24:647–654. doi: 10.1016/j.joca.2015.11.014. PubMed DOI

Kortekaas M., Kwok W.Y., Reijnierse M., Huizinga T.W.J., Kloppenburg M. In erosive hand osteoarthritis more inflammatory signs on ultrasound are found than in the rest of hand osteoarthritis. Ann. Rheum. Dis. 2012;72:930–934. doi: 10.1136/annrheumdis-2012-201458. PubMed DOI

Chow Y.Y., Chin K.-Y. The Role of inflammation in the pathogenesis of osteoarthritis. Mediat. Inflamm. 2020;2020:1–19. doi: 10.1155/2020/8293921. PubMed DOI PMC

Scanzello C.R. Chemokines and inflammation in osteoarthritis: Insights from patients and animal models. J. Orthop. Res. 2017;35:735–739. doi: 10.1002/jor.23471. PubMed DOI PMC

Giordano R., Petersen K.K., Andersen H.H., Simonsen O., Arendt-Nielsen L. Serum inflammatory markers in patients with knee osteoarthritis. Clin. J. Pain. 2020;36:229–237. doi: 10.1097/AJP.0000000000000804. PubMed DOI

Zhao X., Yang Z., Zhang Z., Kang Y., Huang G., Wang S., Huang H., Liao W., Zhang Z. CCL3 serves as a potential plasma biomarker in knee degeneration (osteoarthritis) Osteoarthr. Cartil. 2015;23:1405–1411. doi: 10.1016/j.joca.2015.04.002. PubMed DOI

Funck-Brentano T., Nethander M., Movérare-Skrtic S., Richette P., Ohlsson C. Causal factors for knee, hip, and hand osteoarthritis: A Mendelian randomization study in the UK biobank. Arthritis Rheumatol. 2019;71:1634–1641. doi: 10.1002/art.40928. PubMed DOI PMC

Van Delft M.A.M., Van Beest S., Kloppenburg M., Trouw L.A., Ioan-Facsinay A. Presence of autoantibodies in erosive hand osteoarthritis and association with clinical presentation. J. Rheumatol. 2018;46:101–105. doi: 10.3899/jrheum.180256. PubMed DOI

Altman R., Alarcon G., Appelrouth D., Bloch D., Borenstein D., Brandt K., Brown C., Cooke T.D., Daniel W., Gray R., et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum. 1990;33:1601–1610. doi: 10.1002/art.1780331101. PubMed DOI

Bellamy N., Campbell J., Haraoui B., Gerecz-Simon E., Buchbinder R., Hobby K., MacDermid J. Clinimetric properties of the AUSCAN Osteoarthritis Hand Index: An evaluation of reliability, validity and responsiveness. Osteoarthr. Cartil. 2002;10:863–869. doi: 10.1053/joca.2002.0838. PubMed DOI

Dreiser R.L., Maheu E., Guillou G.B., Caspard H., Grouin J.M. Validation of an algofunctional index for osteoarthritis of the hand. Rev. Rhum. Engl. Ed. 1995;62:43S–53S. PubMed

Kellgren J.H., Lawrence J.S. Radiological assessment of osteo-arthrosis. Ann. Rheum. Dis. 2008;16:494–502. doi: 10.1136/ard.16.4.494. PubMed DOI PMC

Kallman D.A., Wigley F.M., Scott W.W., Hochberg M.C., Tobin J.D. New radiographic grading scales for osteoarthritis of the hand. Reliability for determining prevalence and progression. Arthritis Rheum. 1989;32:1584–1591. doi: 10.1002/anr.1780321213. PubMed DOI

Kropáčková T., Šléglová O., Růžičková O., Vencovský J., Pavelka K., Šenolt L. Lower serum clusterin levels in patients with erosive hand osteoarthritis are associated with more pain. BMC Musculoskelet. Disord. 2018;19:264. doi: 10.1186/s12891-018-2179-3. PubMed DOI PMC

Hurnakova J., Zavada J., Hánová P., Hulejová H., Klein M., Mann H., Šléglová O., Olejárová M., Forejtova S., Růžičková O., et al. Serum calprotectin (S100A8/9): An independent predictor of ultrasound synovitis in patients with rheumatoid arthritis. Arthritis Res. 2015;17:252. doi: 10.1186/s13075-015-0764-5. PubMed DOI PMC

R Core Team . R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; Vienna, Austria: 2020.

Grömping U. Inference with linear equality and inequality constraints UsingR: The Packageic.infer. J. Stat. Softw. 2010;33:1–31. doi: 10.18637/jss.v033.i10. PubMed DOI

Wickham H., Averick M., Bryan J., Chang W., McGowan L.D., François R., Grolemund G., Hayes A., Henry L., Hester J., et al. Welcome to the Tidyverse. J. Open Source Softw. 2019;4:1686. doi: 10.21105/joss.01686. DOI

Venables W.N., Ripley B.D. Modern Applied Statistics with S-Plus. Springer New York; New York, NY, USA: 2002. (Statistics and Computing).

Wickham H. ggplot2. Springer New York; New York, NY, USA: 2009.

Wittoek R., Carron P., Verbruggen G. Structural and inflammatory sonographic findings in erosive and non-erosive osteoarthritis of the interphalangeal finger joints. Ann. Rheum. Dis. 2010;69:2173–2176. doi: 10.1136/ard.2010.128504. PubMed DOI

Punzi L., Ramonda R., Oliviero F., Sfriso P., Mussap M., Plebani M., Podswiadek M., Todesco S. Value of C reactive protein in the assessment of erosive osteoarthritis of the hand. Ann. Rheum. Dis. 2005;64:955–957. doi: 10.1136/ard.2004.029892. PubMed DOI PMC

Dolzani P., Assirelli E., Pulsatelli L., Addimanda O., Mancarella L., Peri G., Mantovani A., Facchini A., Meliconi R. Systemic inflammation and antibodies to citrullinated peptides in hand osteoarthritis. Clin. Exp. Rheumatol. 2011;29:1006–1009. PubMed

Hulejová H., Barešová V., Klézl Z., Polanská M., Adam M., Šenolt L. Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone. Cytokine. 2007;38:151–156. doi: 10.1016/j.cyto.2007.06.001. PubMed DOI

Nees T.A., Rosshirt N., Zhang J.A., Reiner T., Sorbi R., Tripel E., Walker T., Schiltenwolf M., Hagmann S., Moradi B. Synovial cytokines significantly correlate with osteoarthritis-related knee pain and disability: Inflammatory mediators of potential clinical relevance. J. Clin. Med. 2019;8:1343. doi: 10.3390/jcm8091343. PubMed DOI PMC

Snelling S.J.B., Bas S., Puskas G.J., Dakin S.G., Suva D., Finckh A., Gabay C., Hoffmeyer P., Carr A.J., Lubbeke-Wolff A. Presence of IL-17 in synovial fluid identifies a potential inflammatory osteoarthritic phenotype. PLoS ONE. 2017;12:e0175109. doi: 10.1371/journal.pone.0175109. PubMed DOI PMC

Liu S.-C., Hsu C.-J., Fong Y.-C., Chuang S.-M., Tang C. CTGF induces monocyte chemoattractant protein-1 expression to enhance monocyte migration in human synovial fibroblasts. Biochim. Biophys. Acta (BBA)-Bioenerg. 2013;1833:1114–1124. doi: 10.1016/j.bbamcr.2012.12.014. PubMed DOI

Houard X., Goldring M.B., Berenbaum F. Homeostatic mechanisms in articular cartilage and role of inflammation in osteoarthritis. Curr. Rheumatol. Rep. 2013;15:1–10. doi: 10.1007/s11926-013-0375-6. PubMed DOI PMC

Berenbaum F., Griffin T.M., Liu-Bryan R. Review: Metabolic regulation of inflammation in osteoarthritis. Arthritis Rheumatol. 2017;69:9–21. doi: 10.1002/art.39842. PubMed DOI PMC

Hsu Y.-H., Hsieh M.-S., Liang Y.-C., Li C.-Y., Sheu M.-T., Chou D.-T., Chen T.-F., Chen C.-H. Production of the chemokine eotaxin-1 in osteoarthritis and its role in cartilage degradation. J. Cell. Biochem. 2004;93:929–939. doi: 10.1002/jcb.20239. PubMed DOI

Baba T., Mukaida N. Role of macrophage inflammatory protein (MIP)-1α/CCL3 in leukemogenesis. Mol. Cell. Oncol. 2014;1:e29899. doi: 10.4161/mco.29899. PubMed DOI PMC

Ibi M., Horie S., Kyakumoto S., Chosa N., Yoshida M., Kamo M., Ohtsuka M., Ishisaki A. Cell-cell interactions between monocytes/macrophages and synoviocyte-like cells promote inflammatory cell infiltration mediated by augmentation of MCP-1 production in temporomandibular joint. Biosci. Rep. 2018;38 doi: 10.1042/BSR20171217. PubMed DOI PMC

He Y., Liang X., Wu X., Meng C., Wu B., Fu D., Jin S., Yang S., Wang H. Association between interleukin 8−251 A/T and +781 C/T polymorphisms and osteoarthritis risk. Immunol. Lett. 2014;162:207–211. doi: 10.1016/j.imlet.2014.08.018. PubMed DOI

Oliviero F., Ramonda R., Scanu A., Galozzi P., Favero M., Punzi L. Levels of inflammatory cytokines and metalloproteinases are increased in knee synovial fluid of patients with concomitant erosive hand osteoarthritis. Clin. Exp. Rheumatol. 2020;38:800. PubMed

Meliconi R., Pulsatelli L. Are mechanisms of inflammation joint-specific in osteoarthritis? Rheumatology. 2018;58:743–745. doi: 10.1093/rheumatology/key300. PubMed DOI

Miyabe Y., Lian J., Miyabe C., Luster A.D. Chemokines in rheumatic diseases: Pathogenic role and therapeutic implications. Nat. Rev. Rheumatol. 2019;15:731–746. doi: 10.1038/s41584-019-0323-6. PubMed DOI

Baraliakos X., Gensler L.S., D’Angelo S., Iannone F., Favalli E.G., De Peyrecave N., Auteri S.E., Caporali R. Biologic therapy and spinal radiographic progression in patients with axial spondyloarthritis: A structured literature review. Ther. Adv. Musculoskelet. Dis. 2020;12:1759720x2090604. doi: 10.1177/1759720X20906040. PubMed DOI PMC

Schmid A.S., Neri D. Advances in antibody engineering for rheumatic diseases. Nat. Rev. Rheumatol. 2019;15:197–207. doi: 10.1038/s41584-019-0188-8. PubMed DOI

Taylor P. Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases. Curr. Opin. Pharmacol. 2010;10:308–315. doi: 10.1016/j.coph.2010.01.005. PubMed DOI

Aitken D., Laslett L.L., Pan F., Haugen I.K., Otahal P., Bellamy N., Bird P., Jones G. A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand OsteoaRthritis-the HUMOR trial. Osteoarthr. Cartil. 2018;26:880–887. doi: 10.1016/j.joca.2018.02.899. PubMed DOI

Philp A.M., Davis E.T., Jones S.W. Developing anti-inflammatory therapeutics for patients with osteoarthritis. Rheumatology. 2016;56:kew278. doi: 10.1093/rheumatology/kew278. PubMed DOI

Kloppenburg M., Peterfy C., Haugen I.K., Kroon F., Chen S., Wang L., Liu W., Levy G., Fleischmann R.M., Berenbaum F., et al. Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis. Ann. Rheum. Dis. 2019;78:413–420. doi: 10.1136/annrheumdis-2018-213336. PubMed DOI PMC

Shin K., Kim J.W., Moon K.W., Yang J.A., Lee E.Y., Song Y.W., Lee E.B. The efficacy of Diacerein in hand osteoarthritis: A double-blind, randomized, placebo-controlled study. Clin. Ther. 2013;35:431–439. doi: 10.1016/j.clinthera.2013.02.009. PubMed DOI